An animation by Espen Folmo, PhD & Nini Skarpaas Myhrvold.
Cannabis is known as one of the wisest medicinal plants, offering numerous health benefits due to its adaptogenic properties. This means that it has the unique ability to read the body’s imbalances, thereby aiding in pain relief, anxiety reduction, neuroprotection, promoting healthy sleep, reducing inflammation-related conditions, and stimulating appetite.
Both the medical and cosmetics and skincare industries have witnessed an explosive interest in this plant, as advanced techniques now enable the extraction of CBD oil from cannabis, offering scientifically supported benefits without the psychoactive effects of THC.
Sri Lanka’s unique geographical location provides ideal sun and light conditions for growing medical cannabis and hemp, with consistent 12-hour daylight and 12-hour nighttime cycles throughout the year. This is necessary to develop the plant’s medical properties.
As the market demonstrates a lack of supply of high-quality medical cannabis, the Sri Lankan government is currently amending their law to establish the cannabis industry to meet this demand.
Still, mindful of the reputation of this plant, they wish to regulate which companies can take advantage of this excellent environment for such purposes. Ceycana is currently one of the few companies with such authorization.
The company’s ownership and leadership hail from Norway. The founders of Ceycana have earned the trust of the local population by not only offering a tailor-made product portfolio and enabling product expansion, including infused teas, beverages, and partnerships with leading brands, but also by committing to benefiting the local population. Three members of the management team each have more than 10 years of work experience in Sri Lanka and have fallen in love with the country and culture.
By harnessing the medical properties of this ancient medicinal plant, Ceycana aims to develop innovative and effective cannabis-based products to improve the lives of people around the world. To produce high-quality, sustainably grown cannabis and hemp, Ceycana collaborates with world-leading experts and researchers on cannabis and are supported by the friendly population of Sri Lanka – enriched by Buddhist wisdom for thousands of years.
Ceycana aims to create first-class products for consumers while generating considerable benefits for multiple stakeholders. Many renowned analysts have predicted that the cannabis industry will be one of the few capable of competing with the acceleration expected in AI, blockchain, and green technology once the potential has been fully explored. Hence, both major hedge funds as well as retail investors have holdings, have holdings in individual cannabis companies or ETFs. Consequently, Ceycana may be an excellent way to diversify into emerging markets.
Ceycana is a pioneering company on a mission to harness the power of cannabis for medicinal, industrial, and nutraceutical applications while uplifting local communities and embracing the highest standards of ethical and sustainable practices. It offers a unique investment opportunity as Sri Lanka has just opened its optimal environment to foster such a project.
Interesting findings:
* Chronic Pain: A 2015 study found cannabis/cannabinoids effective at reducing pain, including neuropathic pain.
* MS Management: A 2012 study found THC/CBD oral cannabis extract reduced muscle stiffness, pain, and sleep disturbances in MS patients.
* Epilepsy & Seizure Control: In 2018, FDA approved Epidiolex, a CBD-based drug, for treating severe epilepsy forms.
* Chemotherapy-Induced Nausea/Vomiting: A 2015 review found oral cannabinoids more effective than conventional antiemetics.
* Anxiety Reduction: A 2011 study found CBD reduced anxiety in social anxiety disorder patients during a public speaking test.
* Parkinson’s Management: A 2014 study found cannabis improved motor function, pain, sleep, and quality of life in Parkinson’s patients.
* Glaucoma Treatment: A 1971 study showed marijuana temporarily lowered intraocular pressure in glaucoma patients.
* Sleep Improvement: A 2008 study found synthetic cannabinoid, nabilone, improved sleep quality in fibromyalgia patients.
* Appetite Stimulation: A 1995 study found THC stimulated appetite in advanced cancer patients experiencing weight loss.
* PTSD Management: A 2014 study found PTSD patients using cannabis had reduced symptoms.
* Crohn’s Disease Improvement: A small 2013 study found smoking cannabis cigarettes improved Crohn’s disease in 10 of 11 patients.
* IBD Treatment Potential: A 2016 review suggested cannabinoids like THC/CBD may treat IBD due to anti-inflammatory and immunomodulatory effects.
